Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Nuvo Research Inc T.NRI

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  NRIFF| NRIFD

Nuvo Research Inc is a specialty pharmaceutical company with manufacturing operations. The Company operates two distinct business units, the Topical Products and Technology (TPT) Group and the Immunology Group.
Price: $5.37 | Change: $-0.09 | %Change: -1.65%
Volume: 18,747 | Day High/Low: 5.48/5.34 | 52 Week High/Low: 10.36/2.57
View modes: 
0 stars

Pollen Tsunami in Southern Ontario

It was a brutal pollen season up to at least early mid-July as a rare pollen Vortex took its course. Anyone have pollen indices for more recent weeks ?  rate and reply
5 stars

RE:RE:RE:RE:RE:I have high hopes for this stock

I have a strong feeling you're the one in deep waters and now are trying to convince yourself. My advise to you,  do as you preach.  rate and reply
1 star

RE:RE:RE:RE:RE:I have high hopes for this stock

Well put my friend, well put.  rate and reply
2.5 stars

RE:RE:RE:RE:I have high hopes for this stock

The company was trading at 5 cents when current management took over  the bankrupt shell in 2005. Subsequently, the share price rise to 40+ cents on several occaisons. You never sold ? Or do you...read more
5 stars

RE:RE:RE:I have high hopes for this stock

Bod/mgmt as always will continue do extremely well at the expense of common sh. To expect a different outcome after 10 years (despite the current promise!) is by definition, crazy. Unless pressure is...read more
5 stars

RE:RE:I have high hopes for this stock

Indeed its WF10 that has the potential to take our SP over the top as seen in January. My only concern will be the effect that some slick talking negotiator has on our BOD when they start talking...read more
1 star

RE:I have high hopes for this stock

Whether revenues are $6 million or $12 million in Q2 wont make or break this investment. The sentiment on this board is overwhelmingly at the $6 million range and significant cash burn.  Anything...read more
3.5 stars

I have high hopes for this stock

Shows up are very undervalued.  I'm reading it at 10+ stock in value. Something tells me Q2 will be either very good or very bad... Humm.   LOL Too bad I know zero on healthcare, flying this on...read more
5 stars

Horizon patents and trademarks pennsaid

http://www.stockhouse.com/news/press-releases/2015/07/31/horizon-pharma-plc-announces-the-u-s-patent-and-trademark-office-issuance-of-an  rate and reply
0 stars

Next Week

Almost certainly, Q2 financials and product rate clarification. That repport presumably will include a full update on all streaming activities of a material natture that are currently underway..P2...read more
3.5 stars

RE:RE:RE:RE:RE:RE:RE:RE:Q2

gre8t stuff..........soooo much uphoria on nUvo manergement has did such a gre8t job at creating such a buzz around this stock........and all such intelligent posts by some of the highest of...read more
5 stars

RE:RE:RE:RE:RE:RE:RE:Q2

I guess T D falls in the category of vipers.  rate and reply
1 star

RE:RE:RE:RE:RE:RE:Q2

you will never taste it....  rate and reply
0 stars

RE:RE:RE:RE:RE:Q2

Horizon's second quarter 2015 financial results will be released on Friday Aug. 7, 2015.  rate and reply
5 stars

RE:RE:RE:RE:RE:Q2

I'll take  T D advise and  wait  for $ 4.00 .  rate and reply
0 stars

RE:RE:RE:RE:Q2

Good point. TNuvo will need to reference P2 sales in Q2, and that cant happen until Horizon reports on Aug 4....  rate and reply
0 stars

RE:Forward Glancing

Well put Rock. I agree that maintaing current P2 sales levels in the US  through the summer sets up for another increase through the fall and winter. The pace of sales also suggests that the original...read more
0 stars

RE:RE:RE:Q2

Its unlikely that Nuvo will announce its Q2 before Horizon. Aug 4 is Horizon's release date.  rate and reply
3.5 stars

Forward Glancing

There are several factors driving sales of topical Nsaids in the US. Interannually, Obamacare has expanded the scrioted patient population. Secondly, there is a substantial shift from oral Nsaids to...read more
2.5 stars

RE:2j you are both wrong and offensive

Indeed not. You voted in two former auto execs with no background in biotech. Nuvo was bankrupt at that time. Funds had to be raised and new execs had to learn the ropes. The original deal with...read more